Metabolic Mechanisms in Obesity and Type 2 Diabetes: Insights from Bariatric/Metabolic Surgery

Related Experiment Video

Updated: Mar 30, 2026

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

1.2K

Adriana Florinela Cătoi1, Alina Pârvu, Adriana Mureşan

  • 1Department of Functional Biosciences, Faculty of Medicine, x2018;Iuliu Hax0163;ieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Obesity Facts
|November 20, 2015
PubMed

Insights

Bariatric surgery aids type 2 diabetes mellitus (T2DM) remission through mechanisms beyond weight loss. Understanding these gastrointestinal changes improves T2DM pathogenesis insights.

Area of Science:

  • Metabolic disease
  • Gastroenterology
  • Endocrinology

Background:

  • Obesity and type 2 diabetes mellitus (T2DM) are global health concerns.
  • Bariatric/metabolic surgery is an effective treatment for obesity and T2DM.
  • The precise metabolic defects causing T2DM and their reversal by surgery are not fully understood.

Purpose of the Study:

  • To review metabolic mechanisms in T2DM development in obese patients.
  • To explore mechanisms of T2DM remission following bariatric/metabolic surgery.

Main Methods:

  • Literature review of metabolic effects of bariatric/metabolic surgery.
  • Analysis of mechanisms including incretins, bile acids, and gut microbiota.
  • Discussion of the interplay between insulin resistance and hyperinsulinemia.

Main Results:

  • Bariatric surgery induces T2DM remission via multiple pathways.
  • Mechanisms include altered incretin system, bile acid metabolism, and gut microbiota.
  • Weight loss and food restriction are not the sole contributors to T2DM remission.

Conclusions:

  • Elucidating surgical mechanisms enhances understanding of T2DM pathogenesis.
  • Targeting these metabolic pathways may offer novel therapeutic strategies for T2DM.
  • Further research is needed to fully define the role of each mechanism in T2DM remission.

More Related Videos

Sleeve Gastrectomy in Mice using Surgical Clips05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

7.6K
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.9K

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K